Home/Filings/4/A/0000950170-24-138847
4/A//SEC Filing

Judkins Brian C 4/A

Accession 0000950170-24-138847

CIK 0000019584other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 10:38 AM ET

Size

12.4 KB

Accession

0000950170-24-138847

Insider Transaction Report

Form 4/AAmended
Period: 2024-03-20
Judkins Brian C
VP and Chief Legal Officer
Transactions
  • Exercise/Conversion

    Capital Stock

    2024-03-20$413.19/sh+5,825$2,406,8326,558 total
  • Exercise/Conversion

    Capital Stock

    2024-03-20$471.74/sh+6,133$2,893,18112,691 total
  • Exercise/Conversion

    Stock Option (right to buy with tandem tax withholding)

    2024-03-20$471.74/sh6,133$2,893,18123,050 total
    Exercise: $471.74Exp: 2025-10-29Capital Stock (6,133 underlying)
  • Sale

    Capital Stock

    2024-03-20$645.00/sh11,158$7,196,9101,533 total
  • Exercise/Conversion

    Stock Option (right to buy with tandem tax withholding)

    2024-03-20$413.19/sh5,825$2,406,83229,183 total
    Exercise: $413.19Exp: 2024-10-29Capital Stock (5,825 underlying)
Footnotes (4)
  • [F1]Amended filing due to administrative error
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
  • [F3]Vesting in three equal annual installments commencing 10/29/2020
  • [F4]Vesting in three equal annual installments commencing 10/29/2021

Documents

1 file

Issuer

CHEMED CORP

CIK 0000019584

Entity typeother

Related Parties

1
  • filerCIK 0001823398

Filing Metadata

Form type
4/A
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 10:38 AM ET
Size
12.4 KB